NCT06583148 A Smoke-Free Home Intervention in Tribal Communities
| NCT ID | NCT06583148 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Tobacco-Related Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 575 participants |
| Start Date | 2024-11-15 |
| Primary Completion | 2028-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 575 participants in total. It began in 2024-11-15 with a primary completion date of 2028-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention in rural tribal communities. Smoke-free policies, including those that target homes, can reduce exposure to secondhand smoke and support smoking cessation. Rural and racial/ethnic inequities intersect to increase tobacco-related harms among Indigenous populations. A smoke-free home program may improve the health of the household as well as impact smoking behavior among the family unit by reducing secondhand smoke exposure.
Eligibility Criteria
Inclusion Criteria: * 18 years of age and older * Self-report as being a smoker or living with a smoker * Indicate that they do not reside in a smoke-free home * Identify as living in an American Indian household Exclusion Criteria: * Children under the age of 18 will not be included
Contact & Investigator
Michelle Kegler, DrPH, MPH
PRINCIPAL INVESTIGATOR
Emory University Hospital/Winship Cancer Institute
Frequently Asked Questions
Who can join the NCT06583148 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tobacco-Related Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06583148 currently recruiting?
Yes, NCT06583148 is actively recruiting participants. Contact the research team at josh.kaufmann@emory.edu for enrollment information.
Where is the NCT06583148 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT06583148 clinical trial?
NCT06583148 is sponsored by Emory University. The principal investigator is Michelle Kegler, DrPH, MPH at Emory University Hospital/Winship Cancer Institute. The trial plans to enroll 575 participants.